Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Spiny mice can regenerate damaged kidneys without fibrosis

Nov. 10, 2021

Effective attenuation of renal fibrosis with a potent HIPK2 inhibitor

Nov. 10, 2021

Beta2-integrins as potential targets for ANCA-mediated glomerulonephritis

Nov. 10, 2021

IL-33, a potential new therapeutic target for diabetic kidney disease

Nov. 10, 2021

New mouse model allows investigation of EP3 receptor function in the kidney tubule

Nov. 10, 2021

ADX-097 displays targeted complement inhibition in tissues

Nov. 9, 2021

L-WNK1 inhibition as novel therapeutic strategy for protection from glomerular injury

Nov. 9, 2021

Novel small molecule K+ secretagogue RDX-013 for treating hyperkalemia

Nov. 8, 2021

Novel UOX-iKO mouse as model of hyperuricemia

Nov. 8, 2021

Mineralocorticoid receptor antagonism ameliorates DKD phenotype in mice

Nov. 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.